Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding Consultant
Toronto, Ontario, June 30, 2021 – Psyched Wellness Ltd. (CSE:PSYC, OTCQB:PSYCF, FRANKFURT:5U9) (the “Company” or “Psyched”) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that Matthew Singh has joined the team as a consultant to execute managements go-to-market branding and sales strategy for its AME-1 derived consumer products.
Mr. Singh has a proven track record of success launching brands, products, departments, and national business units within the multibillion-dollar beverage and pharmaceutical industries. He is currently the head of VPX Pharmaceuticals’ numerous CPG properties in Canada, where he has secured immediate profitability for each new Sports Nutrition, Energy Drink, Cannabis, and Alcoholic good VPX launched. Prior to VPX, Mr. Singh spent almost a decade at Red Bull Canada, where he ran the company’s Business Development department, and spent over seven years with Coca Cola. In addition to this, he is an integral contributor for multiple start-up entities as a consultant, board member and board strategic advisor within the Health and Wellness, and Digital Intelligence verticals.
Mr. Singh stated: “I have been fortunate to work with industry leaders and market disruptors in the extremely competitive beverage and pharmaceutical landscapes and I can confidently say the CPG potential being developed by the team at Psyched Wellness has me more excited than anything I have witnessed in my career thus far. We truly believe this product will have a sustainable commercial and societal impact, starting in North America and then scaling up globally. I believe Amanita will change the world with its power to help stress relief, relaxation, assist with restful sleeping, and I am proud to be a part of the journey. My thanks to Jeff, David, and the Board for adding me to an already stellar team,” Mr. Singh said.
Jeff Stevens, CEO of Psyched said: “We are thrilled to have Matt join the team at Psyched Wellness to drive our branding and sales strategy. He brings an invaluable amount of experience and expertise in all things CPG, and he will be integral in driving the continual development of the Company’s go-to-market strategy. We are on track to file our application with the FDA for a New Dietary Ingredient (NDI) and Health Canada for a Natural Health Product Number (NHPN) in December 2021, when the pre-clinical trials are completed. This positions Psyched Wellness to be able to begin marketing products in both countries in the first half of 2022. Initiating the branding and marketing strategy now affords us enough time to hit the ground running in the first half of 2022,” said Jeff Stevens, CEO of Psyched Wellness.